Komander David, Clague Michael J, Urbé Sylvie
Medical Research Council, Laboratory of Molecular Biology, Hills Road, Cambridge, CB2 0QH, UK.
Nat Rev Mol Cell Biol. 2009 Aug;10(8):550-63. doi: 10.1038/nrm2731.
Ubiquitylation is a reversible protein modification that is implicated in many cellular functions. Recently, much progress has been made in the characterization of a superfamily of isopeptidases that remove ubiquitin: the deubiquitinases (DUBs; also known as deubiquitylating or deubiquitinating enzymes). Far from being uniform in structure and function, these enzymes display a myriad of distinct mechanistic features. The small number (<100) of DUBs might at first suggest a low degree of selectivity; however, DUBs are subject to multiple layers of regulation that modulate both their activity and their specificity. Due to their wide-ranging involvement in key regulatory processes, these enzymes might provide new therapeutic targets.
泛素化是一种可逆的蛋白质修饰,与许多细胞功能相关。最近,在去除泛素的异肽酶超家族(去泛素化酶,DUBs;也称为去泛素化酶)的特性研究方面取得了很大进展。这些酶在结构和功能上远非统一,而是展现出无数独特的机制特征。DUBs数量较少(<100种),这乍一看可能表明其选择性程度较低;然而,DUBs受到多层调节,这些调节会同时调控它们的活性和特异性。由于它们广泛参与关键调节过程,这些酶可能提供新的治疗靶点。